Cargando…

Temporal trajectory of biofluid markers in Parkinson’s disease

Full dynamics of biofluid biomarkers have been unknown in patients with Parkinson’s disease (PD). Using data from 396 PD patients and 182 controls in the Parkinson's Progression Markers Initiative (PPMI) database, we estimated long-term temporal trajectories of CSF α-synuclein (α-syn), amyloid-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baek, Min Seok, Lee, Myung Jun, Kim, Han-Kyeol, Lyoo, Chul Hyoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292456/ https://www.ncbi.nlm.nih.gov/pubmed/34285331 http://dx.doi.org/10.1038/s41598-021-94345-8

Ejemplares similares

Asymmetric Parkinsonism With Progressive Nigrosomal Change Secondary to Kernohan’s Notch Phenomenon
por: Kim, Han-Kyeol, et al.
Publicado: (2022)

Genetic factors affecting dopaminergic deterioration during the premotor stage of Parkinson disease
por: Lee, Myung Jun, et al.
Publicado: (2021)

Author Correction: Genetic factors affecting dopaminergic deterioration during the premotor stage of Parkinson disease
por: Lee, Myung Jun, et al.
Publicado: (2022)

Clinical Features Indicating Nigrostriatal Dopaminergic Degeneration in Drug-Induced Parkinsonism
por: Lee, Seung Ha, et al.
Publicado: (2017)

Combining clinical and biofluid markers for early Parkinson's disease detection
por: Yu, Zhenwei, et al.
Publicado: (2017)

Annual Trends in the Incidence and Prevalence of Alzheimer's Disease in South Korea: A Nationwide Cohort Study
por: Baek, Min Seok, et al.
Publicado: (2022)

Dynamic network model reveals distinct tau spreading patterns in early- and late-onset Alzheimer disease
por: Lee, Wha Jin, et al.
Publicado: (2022)

Biofluid Markers for Prodromal Parkinson's Disease: Evidence From a Catecholaminergic Perspective
por: Vermeiren, Yannick, et al.
Publicado: (2020)

Status of Current Biofluid Biomarkers in Parkinson's Disease
por: Mollenhauer, Brit
Publicado: (2023)

Premorbid cancer and motor reserve in patients with Parkinson’s disease
por: Oh, Yoon-Sang, et al.
Publicado: (2022)

Author Correction: Premorbid cancer and motor reserve in patients with Parkinson’s disease
por: Oh, Yoon‑Sang, et al.
Publicado: (2022)

Exploring the link between essential tremor and Parkinson’s disease
por: Yoo, Sang-Won, et al.
Publicado: (2023)

A Patient with Recurrent Dyskinesia and Hyperpyrexia Syndrome
por: Baek, Min Seok, et al.
Publicado: (2017)

In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease
por: Chahine, Lana M., et al.
Publicado: (2020)

New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia
por: del Campo, Marta, et al.
Publicado: (2022)

Presynaptic Dopaminergic Dysfunction Was Overestimated in Huntington’s Disease Presenting as Young Age-Onset Parkinsonism
por: Kim, Taewon, et al.
Publicado: (2022)

Plasma pS129-α-Synuclein Is a Surrogate Biofluid Marker of Motor Severity and Progression in Parkinson’s Disease
por: Lin, Chin-Hsien, et al.
Publicado: (2019)

Decreased thalamic monoamine availability in drug-induced parkinsonism
por: Oh, Yoon-Sang, et al.
Publicado: (2022)

Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms
por: Lyoo, Chul Hyoung, et al.
Publicado: (2018)

Author Correction: Decreased thalamic monoamine availability in drug-induced parkinsonism
por: Oh, Yoon-Sang, et al.
Publicado: (2022)

Risks and Prognoses of Alzheimer's Disease and Vascular Dementia in Patients With Insomnia: A Nationwide Population-Based Study
por: Baek, Min Seok, et al.
Publicado: (2021)

Impact of Prolonged Temporal Discrimination Threshold on Finger Movements of Parkinson’s Disease
por: Lee, M. J., et al.
Publicado: (2016)

Neuroleptic Malignant Syndrome in a Patient with Corticobasal Degeneration
por: Lee, Myung Jun, et al.
Publicado: (2011)

Extracellular vesicles in the study of Alzheimer's and Parkinson's diseases: Methodologies applied from cells to biofluids
por: Vaz, Margarida, et al.
Publicado: (2022)

Effect of A/T/N imaging biomarkers on impaired odor identification in Alzheimer's disease
por: Baek, Min Seok, et al.
Publicado: (2020)

Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease
por: Baek, Min Seok, et al.
Publicado: (2020)

Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease
por: Cho, Hanna, et al.
Publicado: (2020)

Association between physical activity and conversion from mild cognitive impairment to dementia
por: Kim, Yeo Jin, et al.
Publicado: (2020)

Alteration of Sphingolipids in Biofluids: Implications for Neurodegenerative Diseases
por: Pujol-Lereis, Luciana M.
Publicado: (2019)

Metabonomics: Mining for Metabolites in Biofluids
Publicado: (2002)

The effect of levodopa on bilateral coordination and gait asymmetry in Parkinson’s disease using inertial sensor
por: Son, Minji, et al.
Publicado: (2021)

A Patient with Genetically Confirmed Myoclonus-Dystonia Responded to Anticholinergic Treatment and Improved Spontaneously
por: Lee, Jae Hyeok, et al.
Publicado: (2011)

Evaluation of peripherin in biofluids of patients with motor neuron diseases
por: Sabbatini, Daniele, et al.
Publicado: (2021)

Biofluid Biomarkers of Alzheimer’s Disease: Progress, Problems, and Perspectives
por: Huang, Shan, et al.
Publicado: (2022)

Clinical Proteomics of Biofluids in Haematological Malignancies
por: Dunphy, Katie, et al.
Publicado: (2021)

Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4)
por: Chahine, Lana M., et al.
Publicado: (2018)

Machine Learning Profiling of Alzheimer's Disease Patients Based on Current Cerebrospinal Fluid Markers and Iron Content in Biofluids
por: Ficiarà, Eleonora, et al.
Publicado: (2021)

Parkinsonism and Dementia Associated with Giant Virchow-Robin Spaces
por: Lee, Myung Sik, et al.
Publicado: (2015)

Trajectory Analysis of Orthostatic Hypotension in Parkinson’s Disease: Results From Parkinson’s Progression Markers Initiative Cohort
por: Chen, Kui, et al.
Publicado: (2021)

Artificial Intelligence Analysis of Biofluid Markers in Age-Related Macular Degeneration: A Systematic Review
por: Pucchio, Aidan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4m7aflhfl9k9vqpjan0js8o5sc